Trials / Conditions / Metastatic Squamous Non-Small Cell Lung Cancer
Metastatic Squamous Non-Small Cell Lung Cancer
3 registered clinical trials studyying Metastatic Squamous Non-Small Cell Lung Cancer.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer NCT04205812 | Incyte Corporation | Phase 3 |
| Withdrawn | A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locall NCT02941601 | Eli Lilly and Company | Phase 2 |
| Terminated | Study of Pembrolizumab Maintenance Following First-Line Platinum Based Chemotherapy in Patients With Metastati NCT02564380 | AIO-Studien-gGmbH | Phase 2 |